Pakistan to Launch HPV Vaccination Campaign to Protect Girls from Cervical Cancer
In many low-income countries, limited access to healthcare and resources leads to a higher burden of disease. Regular vaccination campaigns play a critical role in preventing illnesses that disproportionately affect developing nations.
In this context, Pakistan is set to make a major advancement in public health: a phased rollout of the Human Papillomavirus (HPV) vaccine to prevent cervical cancer. The campaign will officially begin on September 15.
Rollout Plan Across Pakistan
-
Sindh: Targeting 4.1 million girls aged 9 to 14 years. Once fully integrated into the Expanded Programme on Immunisation (EPI), the focus will shift to nine-year-olds through school-based outreach.
-
Punjab, Islamabad (ICT) & AJK: Campaign begins simultaneously on Sept 15.
-
Khyber Pakhtunkhwa (KP): Rollout planned for 2026.
-
Balochistan & Gilgit-Baltistan (GB): Implementation expected in 2027.
Why the HPV Vaccine Matters
Cervical cancer often goes undetected in its early stages, especially in countries like Pakistan, where routine pelvic exams and screenings are not common practice. Each year, around 5,000 women in Pakistan are diagnosed with cervical cancer, and tragically, 60% lose their lives. Experts believe the actual numbers may be even higher.
The HPV vaccine is globally recognized as one of the most effective ways to protect young girls from developing cervical cancer later in life. By introducing it into Pakistan’s EPI, the government aims to not only protect millions of girls but also raise awareness among mothers and families about the importance of early prevention and screening.
A Step Toward Safer Futures
Health officials hope that once families see the long-term benefits of the HPV vaccine, more women will also seek regular screenings and consider vaccination themselves. This campaign represents a major step toward reducing cervical cancer rates and saving countless lives.
